CHINA PHARMA HOLDINGS, INC.
CPHIUS売上高
$4M
百万USD
営業利益
$-3M
百万USD
純利益
$-3M
百万USD
ROE
-14.0%
最新FY
EPS
$-0.74
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $2M | $-1M | - |
| FY2021 | Q2 | $2M | $-1M | - |
| FY2021 | Q3 | $2M | $-1M | - |
| FY2021 | FY | $10M | $-3M | - |
| FY2022 | Q1 | $2M | $-1M | - |
| FY2022 | Q2 | $2M | $-1M | $-0.02 |
| FY2022 | Q3 | $2M | $-1M | $-0.02 |
| FY2022 | FY | $8M | $-4M | $-0.76 |
| FY2023 | Q1 | $2M | $-0M | $-0.06 |
| FY2023 | Q2 | $1M | $-1M | $-0.06 |
| FY2023 | Q3 | $2M | $-1M | $-0.06 |
| FY2023 | FY | $7M | $-3M | $-0.91 |
| FY2024 | Q2 | $1M | $-1M | $-0.09 |
| FY2024 | Q3 | $1M | $-1M | $-0.06 |
| FY2024 | FY | $5M | $-5M | $-0.27 |
| FY2025 | Q1 | $1M | $-1M | $-0.24 |
| FY2025 | Q2 | $1M | $-1M | $-0.16 |
| FY2025 | Q3 | $1M | $-1M | $-0.17 |
| FY2025 | FY | $4M | $-3M | $-0.74 |
| FY2026 | Q1 | $1M | $-1M | $-0.04 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | $16M | $13M | $12M | $11M | $11M | $10M | $8M | $7M | $5M | $4M |
| 営業利益 | $-8M | $-19M | $-10M | $-20M | $-3M | $-3M | $-4M | $-3M | $-5M | $-3M |
| 純利益 | $-9M | $-19M | $-11M | $-21M | $-3M | $-3M | $-4M | $-3M | $-5M | $-3M |
| 総資産 | $79M | $60M | $45M | $22M | $21M | $23M | $18M | $16M | $15M | $31M |
| 純資産 | - | - | - | - | - | - | - | - | - | - |
| 自己資本 | $59M | $43M | $30M | $9M | $8M | $6M | $4M | $7M | $8M | $23M |
| 営業CF | $3M | $1M | $1M | $1M | $-0M | $-0M | $-0M | $-1M | $-0M | $0M |
| EPS | - | - | - | - | - | - | $-0.76 | $-0.91 | $-0.27 | $-0.74 |
| BPS | $1.35 | $0.99 | $0.69 | $0.21 | $0.18 | $0.13 | $0.51 | $0.50 | $0.24 | $0.56 |
| ROE | -15.6% | -44.8% | -35.6% | -224.1% | -35.8% | -56.5% | -92.6% | -41.3% | -61.1% | -14.0% |